Literature DB >> 35464893

TIPSS as a bridge to extrahepatic abdominal surgery: a case report.

Audrey Pamela Kapeleris1, Suresh Venkatachalapathy2.   

Abstract

Severe portal hypertension in cirrhosis is a relative contraindication to major surgical intervention. Pre-surgical placement of a transjugular intrahepatic portosystemic shunt (TIPSS) can potentially reduce portal hypertension and the risk of intraoperative bleeding. Two patients in our service, with cirrhosis and portal hypertension, required abdominal surgery and underwent TIPSS placement as a potential bridging therapy. Patient 1, a 56-year-old female, successfully underwent surgery with no intraoperative complications. Patient 2, a 36-year-old male, experienced liver decompensation post-TIPSS and is currently awaiting a liver and bowel transplant. Prophylactic TIPSS placement may allow some patients with decompensated cirrhosis to successfully undergo major extrahepatic abdominal surgery. However, careful patient selection and preoperative counselling for decompensation is necessary.
© The Author(s) 2022. Published by Oxford University Press.

Entities:  

Year:  2022        PMID: 35464893      PMCID: PMC9021974          DOI: 10.1093/omcr/omac029

Source DB:  PubMed          Journal:  Oxf Med Case Reports        ISSN: 2053-8855


INTRODUCTION

More than 10% of patients with cirrhosis will require surgery in the last 2 years of life [1]. Despite progress in perioperative management and surgical techniques, extrahepatic surgery morbidity and mortality can be as high as 50% in these patients compared to ~1% in patients without cirrhosis [2]. A means of improving surgical mortality in patients with cirrhosis is via preoperative placement of a transjugular intrahepatic portosystemic shunts (TIPSS). TIPSS have been used to treat complications of portal hypertension, including bleeding varices, refractory ascites and hepatic hydrothorax. TIPSS placement is less invasive than surgical shunts and can be performed in patients with a higher degree of liver insufficiency [3]. Evidence for preoperative TIPSS placement is still limited and with often contradictory findings. Several large retrospective studies found that certain patients with cirrhosis can safely undergo major surgery after successful portal decompression via TIPSS, while the only comparative study did not observe any improved survival between control and treatment groups [4]. We present two patients who underwent TIPSS as a bridge procedure and their outcomes.

CASE REPORT

Clinical and serological data for all patients pre- and post-TIPSS are summarized in Table 1.
Table 1

Summary of patient demographics, Child-Pugh scores, MELD scores, pre- and post-TIPSS HVPG values and outcomes for all four patients involved in this study; Patient 1 experienced a larger drop in HVPG post-TIPSS than Patient 2

PatientAgeSexChild-Pugh scoreMELD scoreIntended surgeryPre-TIPSS HVPG (mmHg)Post-TIPSS HVPG (mmHG)Outcome
P156FCP A (6)9LAR337LAR successful
P236MCP B (9)11Total colectomy2219Thrombosed TIPSS, awaiting liver and bowel transplant
Summary of patient demographics, Child-Pugh scores, MELD scores, pre- and post-TIPSS HVPG values and outcomes for all four patients involved in this study; Patient 1 experienced a larger drop in HVPG post-TIPSS than Patient 2

Case 1: 56-year-old female requiring lower anterior resection

Patient 1 was a 56-year-old female with sigmoid adenocarcinoma who required a lower anterior resection (LAR). Co-morbidities included diabetes, a body mass index of 43 and non-alcoholic steatohepatitis with cirrhosis and oesophageal varices. The best treatment option for Patient 1 was surgical resection following neoadjuvant chemotherapy. But her cirrhosis presented a significant mortality risk. Her Child-Pugh score was 6 and her MELD score was 9. Preoperative TIPSS placement was suggested as a means of reducing portal hypertension and mitigating bleeding risk. As the potential benefit outweighed the risks, the patient underwent the prophylactic TIPSS treatment. Her pre-TIPSS HVPG was 33 mmHg, post-TIPSS pressure measured 7 mmHg. She successfully underwent her LAR and her recovery was uneventful.

Case 2: 36-year-old male requiring colectomy

Patient 2 was a 36-year-old male with ulcerative colitis with dysplasia requiring a colectomy. Medical history included autoimmune hepatitis and primary sclerosing cholangitis with secondary cirrhosis and ascites. His suffered from significant portal hypertension with a Class B(9) Child-Pugh score. His MELD score was 11. He underwent a TIPSS procedure with the goal of decompression via TIPSS placement and potentially improving the outcome of colonic surgery. His pre-TIPSS HVPG was 22 mmHg and post-TIPSS pressure measured 19 mmHg (inadequate pressure reduction). Unfortunately, he received infliximab treatment around the same time the TIPSS was placed, resulting in acute decompensation with ascites and oedema. There was stent thrombosis soon after the infliximab and TIPSS therapies, so it is likely that the treatments initiated decompensation rather than simple disease progression. Ultimately, Patient 2’s TIPSS thrombosed and he is currently on the wait list for a liver and bowel transplant.

DISCUSSION

Cirrhotic patients with portal hypertension present a unique challenge, often having co-morbidities that complicate management [5]. High rates of surgical morbidity and mortality have been reported in patients with cirrhosis undergoing various surgical procedures [6]. Patients with cirrhosis are more susceptible to the adverse hepatic effects of general anaesthesia resulting from reduced hepatic blood flow [7]. Cirrhotic patients also have an increased risk of perioperative bleeding, sepsis, wound dehiscence and renal failure owing to underlying portal hypertension, coagulopathy and impaired reticuloendothelial cell function [8]. Our small case series shows that the trend towards decompensation is bigger if there is inadequate pressure reduction (clinical failure of TIPSS). The body of evidence examining the effects of preoperative TIPSS placement is still quite limited even though the procedure was described over 30 years ago [9]. Vinet et al. (2006) found no benefit of preoperative TIPSS placement when comparing 18 patients who underwent TIPSS compared to 17 matched controls [4]. By contrast, Schmitz et al. (2020) found preoperative TIPSS placement allowed abdominal surgery to be performed on 11 of 21 patients [10]. And Gil et al. (2004) reported that pre-surgery TIPSS placement in three patients reduced portal hypertension by an average of 18 mmHg and allowed all three patients to successfully receive abdominal surgery [11]. Our two case studies show that TIPSS placement is more likely to allow for abdominal surgery if there is significant pressure reduction post-TIPSS. This means that TIPSS may allow some patients with cirrhosis and portal hypertension to successfully undergo major and complex extrahepatic abdominal surgery with reduced intraoperative and post-operative morbidity. However, the risk of decompensation and mortality following TIPSS placement suggests that careful patient selection and preoperative counselling is an absolute necessity.
  10 in total

Review 1.  TIPSS 10 years on.

Authors:  R Jalan; H F Lui; D N Redhead; P C Hayes
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

Review 2.  The risk of surgery in patients with liver disease.

Authors:  L S Friedman
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

3.  Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation Prior to Abdominal Operation: a Retrospective Analysis.

Authors:  Adam Schmitz; Paul Haste; Matthew S Johnson
Journal:  J Gastrointest Surg       Date:  2019-09-04       Impact factor: 3.452

4.  Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study.

Authors:  Evelyne Vinet; Pierre Perreault; Louis Bouchard; Denis Bernard; Ramses Wassef; Carole Richard; Richard Létourneau; Gilles Pomier-Layrargues
Journal:  Can J Gastroenterol       Date:  2006-06       Impact factor: 3.522

5.  Safety and efficacy of combined orthotopic liver transplantation and coronary artery bypass grafting.

Authors:  David Axelrod; Alan Koffron; Andre Dewolf; Alfred Baker; John Fryer; Talia Baker; James Frederiksen; Keith Horvath; Micheal Abecassis
Journal:  Liver Transpl       Date:  2004-11       Impact factor: 5.799

6.  Risk factors for nonhepatic surgery in patients with cirrhosis.

Authors:  Juan A del Olmo; Blas Flor-Lorente; Blas Flor-Civera; Felicidad Rodriguez; Miguel A Serra; Amparo Escudero; Salvador Lledó; José M Rodrigo
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

7.  The role of transjugular intrahepatic portosystemic shunt prior to abdominal tumoral surgery in cirrhotic patients with portal hypertension.

Authors:  A Gil; F Martínez-Regueira; J L Hernández-Lizoain; F Pardo; J M Olea; G Bastarrika; J A Cienfuegos; J I Bilbao
Journal:  Eur J Surg Oncol       Date:  2004-02       Impact factor: 4.424

8.  Morbidity and mortality after operation in nonbleeding cirrhotic patients.

Authors:  R C Doberneck; W A Sterling; D C Allison
Journal:  Am J Surg       Date:  1983-09       Impact factor: 2.565

Review 9.  Transjugular intrahepatic portosystemic shunt: current status.

Authors:  Thomas D Boyer
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

10.  Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.

Authors:  John J Kim; Narasimham L Dasika; Esther Yu; Robert J Fontana
Journal:  J Clin Gastroenterol       Date:  2009-07       Impact factor: 3.062

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.